Global Heparin Market Survey and Trend Research 2018

December 2017 | 85 pages | ID: G404A9EABCCEN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Aspen (N.V.Organon), Aspen (N.V.Organon), King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma Limited, Deebio, SPL(acquired by Hepalink in 2014) etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Heparin Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HEPARIN MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Hepalink (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Changshan Pharm (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Qianhong Bio-pharma (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Opocrin (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Aspen (N.V.Organon) (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Aspen (N.V.Organon) (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 King-friend Biochemical Pharmaceutical (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Bioibérica (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Dongcheng Biochemicals (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Jiulong Biochemicals (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Tiandong (Company Overview, Sales Data etc.)
4.12 Xinbai (Company Overview, Sales Data etc.)
4.13 Yino Pharma Limited (Company Overview, Sales Data etc.)
4.14 Deebio (Company Overview, Sales Data etc.)
4.15 SPL(acquired by Hepalink in 2014) (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Heparin Market 2012-2017, by Type, in USD Million
Table Global Heparin Market 2012-2017, by Type, in Volume
Table Global Heparin Market Forecast 2018-2023, by Type, in USD Million
Table Global Heparin Market Forecast 2018-2023, by Type, in Volume
Table Hepalink Overview List
Table Heparin Business Operation of Hepalink (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changshan Pharm Overview List
Table Heparin Business Operation of Changshan Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Qianhong Bio-pharma Overview List
Table Heparin Business Operation of Qianhong Bio-pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Opocrin Overview List
Table Heparin Business Operation of Opocrin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen (N.V.Organon) Overview List
Table Heparin Business Operation of Aspen (N.V.Organon) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen (N.V.Organon) Overview List
Table Heparin Business Operation of Aspen (N.V.Organon) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table King-friend Biochemical Pharmaceutical Overview List
Table Heparin Business Operation of King-friend Biochemical Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bioibérica Overview List
Table Heparin Business Operation of Bioibérica (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dongcheng Biochemicals Overview List
Table Heparin Business Operation of Dongcheng Biochemicals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jiulong Biochemicals Overview List
Table Heparin Business Operation of Jiulong Biochemicals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tiandong Overview List
Table Heparin Business Operation of Tiandong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Xinbai Overview List
Table Heparin Business Operation of Xinbai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Yino Pharma Limited Overview List
Table Heparin Business Operation of Yino Pharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Deebio Overview List
Table Heparin Business Operation of Deebio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SPL(acquired by Hepalink in 2014) Overview List
Table Heparin Business Operation of SPL(acquired by Hepalink in 2014) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Heparin Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Heparin Sales Revenue Share, by Companies, in USD Million
Table Global Heparin Sales Volume 2012-2017, by Companies, in Volume
Table Global Heparin Sales Revenue Share, by Companies in 2017, in Volume
Table Heparin Demand 2012-2017, by Application, in USD Million
Table Heparin Demand 2012-2017, by Application, in Volume
Table Heparin Demand Forecast 2018-2023, by Application, in USD Million
Table Heparin Demand Forecast 2018-2023, by Application, in Volume
Table Global Heparin Market 2012-2017, by Region, in USD Million
Table Global Heparin Market 2012-2017, by Region, in Volume
Table Heparin Market Forecast 2018-2023, by Region, in USD Million
Table Heparin Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Heparin Industry Chain Structure
Figure Global Heparin Market Growth 2012-2017, by Type, in USD Million
Figure Global Heparin Market Growth 2012-2017, by Type, in Volume
Figure Global Heparin Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Heparin Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region